BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 23044998)

  • 1. Review: ototoxic characteristics of platinum antitumor drugs.
    Ding D; Allman BL; Salvi R
    Anat Rec (Hoboken); 2012 Nov; 295(11):1851-67. PubMed ID: 23044998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cochlear structure and function after round window application of ototoxins.
    Bauer CA; Brozoski TJ
    Hear Res; 2005 Mar; 201(1-2):121-31. PubMed ID: 15721567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell death after co-administration of cisplatin and ethacrynic acid.
    Ding D; Jiang H; Wang P; Salvi R
    Hear Res; 2007 Apr; 226(1-2):129-39. PubMed ID: 16978814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caspase inhibitors, but not c-Jun NH2-terminal kinase inhibitor treatment, prevent cisplatin-induced hearing loss.
    Wang J; Ladrech S; Pujol R; Brabet P; Van De Water TR; Puel JL
    Cancer Res; 2004 Dec; 64(24):9217-24. PubMed ID: 15604295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ototoxicity: therapeutic opportunities.
    Rybak LP; Whitworth CA
    Drug Discov Today; 2005 Oct; 10(19):1313-21. PubMed ID: 16214676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurochemistry of the peripheral and central auditory system after ototoxic drug exposure: implications for tinnitus.
    Rybak LP
    Int Tinnitus J; 2005; 11(1):23-30. PubMed ID: 16419684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A protein derived from the fusion of TAT peptide and FNK, a Bcl-x(L) derivative, prevents cochlear hair cell death from aminoglycoside ototoxicity in vivo.
    Kashio A; Sakamoto T; Suzukawa K; Asoh S; Ohta S; Yamasoba T
    J Neurosci Res; 2007 May; 85(7):1403-12. PubMed ID: 17387707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blebs in inner and outer hair cells: a pathophysiological hypothesis.
    Ramírez-Camacho R; García-Berrocal JR; Trinidad A; Verdaguer JM; Nevado J
    J Laryngol Otol; 2008 Nov; 122(11):1151-5. PubMed ID: 18184450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ototoxicity and Platinum Uptake Following Cyclic Administration of Platinum-Based Chemotherapeutic Agents.
    Gersten BK; Fitzgerald TS; Fernandez KA; Cunningham LL
    J Assoc Res Otolaryngol; 2020 Aug; 21(4):303-321. PubMed ID: 32583132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review of cis-platinum ototoxicity.
    Moroso MJ; Blair RL
    J Otolaryngol; 1983 Dec; 12(6):365-9. PubMed ID: 6686617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ototoxicity among cisplatin, carboplatin, and oxaliplatin in zebrafish model.
    Li KH; Zhao YY; Cheng HL; Yang JJ; Chien CY
    Environ Toxicol; 2024 Jul; 39(7):4058-4065. PubMed ID: 38661261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. OTOTOXIC EFFECTS OF CARBOPLATIN IN ORGANOTYPIC CULTURES IN CHINCHILLAS AND RATS.
    Dalian D; Haiyan J; Yong F; Salvi R; Someya S; Tanokura M
    J Otol; 2012 Dec; 7(2):92-101. PubMed ID: 25593588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lead exposure results in hearing loss and disruption of the cochlear blood-labyrinth barrier and the protective role of iron supplement.
    Liu X; Zheng G; Wu Y; Shen X; Jing J; Yu T; Song H; Chen J; Luo W
    Neurotoxicology; 2013 Dec; 39():173-81. PubMed ID: 24144481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conservation of endocochlear potential in mice with profound hearing loss induced by co-administration of kanamycin and furosemide.
    Xiong H; Chu H; Zhou X; Huang X; Cui Y; Zhou L; Chen J; Li J; Wang Y; Chen Q; Li Z
    Lab Anim; 2011 Apr; 45(2):95-102. PubMed ID: 21216844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Styrene induced alterations in biomarkers of exposure and effects in the cochlea: mechanisms of hearing loss.
    Chen GD; Chi LH; Kostyniak PJ; Henderson D
    Toxicol Sci; 2007 Jul; 98(1):167-77. PubMed ID: 17420221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carboplatin and cisplatin ototoxicity in guinea pigs.
    Taudy M; Syka J; Popelár J; Ulehlová L
    Audiology; 1992; 31(5):293-9. PubMed ID: 1449432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of antioxidants in protection from ototoxic drugs.
    Sergi B; Fetoni AR; Ferraresi A; Troiani D; Azzena GB; Paludetti G; Maurizi M
    Acta Otolaryngol Suppl; 2004 May; (552):42-5. PubMed ID: 15219046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platinum compounds in children with cancer: toxicity and clinical management.
    Ruggiero A; Trombatore G; Triarico S; Arena R; Ferrara P; Scalzone M; Pierri F; Riccardi R
    Anticancer Drugs; 2013 Nov; 24(10):1007-19. PubMed ID: 23962902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative studies of the ototoxicity of cisplatin and carboplatin].
    Delb W; Feilen S; Koch A; Federspil P
    Laryngorhinootologie; 1993 Jan; 72(1):24-7. PubMed ID: 8439352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Consequences of noise- or styrene-induced cochlear damages on glutamate decarboxylase levels in the rat inferior colliculus.
    Pouyatos B; Morel G; Lambert-Xolin AM; Maguin K; Campo P
    Hear Res; 2004 Mar; 189(1-2):83-91. PubMed ID: 14987755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.